The controlled cell line combined with Recipharm’s AAV manufacturing platform is said to allow for consistent and scalable ...

Sickle Cell Disease is a chronic, inherited blood disorder that affects millions of people worldwide. It is best known for ...

Just a few weeks after conception, stem cells are already orchestrating the future structure of the human brain. A new ...

Medulloblastomas, brain tumors in children, are thought to develop between the first trimester of pregnancy and the end of the first year of life. Researchers have now analyzed the genetic changes of ...

A study published in the journal Cell marks the first reported instance of generative AI designing synthetic molecules that ...

Provides ReciBioPharm’s customers with access to NewBiologix’s Xcell-Eng-HEK293 cell lines for advanced therapiesComplements and further expands ReciBioPharm’s AAV offeringAchieves industry-leading ...

Careful planning can make a substantial difference on your path to commercial success. Here we delve into key considerations ...

Medulloblastoma is one of the most common malignant tumors of the central nervous system (CNS) in children and adolescents.

ProBioGen inks agreement with Polpharma Biologics to provide high-performance cell line development services: Gdansk, Poland Friday, May 9, 2025, 17:00 Hrs [IST] ProBioGen, a Berl ...

"An exciting finding was when we tried to treat the obese mice with colon inflammation by lowering their inflammation, it actually stopped the ERK pathway in the liver from activating," explains Imai.

Explore Fate Therapeutics' pipeline, financials, and market position to assess if its 75% drop reflects true value or ...

Researchers just discovered super stem cells capable of resetting themselves back to a stronger, younger version.